Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
DLL3 – A Breakthrough Target for Small Cell Lung Cancer Therapy-DIMA ...
Dll3 Protein Atlas at Bryan Riggs blog
DLL3 Gene - GeneCards | DLL3 Protein | DLL3 Antibody
DLL3 regulates Notch signaling in small cell lung cancer: iScience
Structure of the Notch ligands. Mammalian Notch ligands are single-pass ...
Localization of chimeric DLL1 and DLL3 proteins. (A) Schematic ...
DLL3 Antibody (703623)
Human DLL3 Protein, hFc Tag-DLL3重组蛋白（C-Human Fc Tag）-缔码生物
Structure of the Notch1(11–13)– DLL4 SLP (N-EGF2) complex. (A) The ...
| Structure of Notch receptor family and its ligands. (A) Structure of ...
Dll3 does not activate N signaling in trans. (A) Cell surface ...
DLL3 Is a Prognostic and Potentially Predictive Biomarker for ...
Expression and survival analysis of DLL3. (A-C) IHC staining of DLL3 in ...
A minimal sequence code for switching protein structure and function | PNAS
Henlius’ DLL3 × CD3 × CD28 Tri-specific TCE: An Integration of ...
DLL3 expression in normal and tumor tissue. DLL3 protein expression via ...
DBL domain 3D structure determined by X-ray crystallography A) Head ...
DLL3 (delta-like protein 3) expression correlates with stromal ...
Recombinant Human DLL3 His-tag Alexa Fluor® 647 Protein (AFR9749) by R ...
Investigational DLL3 & T-Cell Engager Technology for SCLC | DLL3 ...
Protein Structure Examples
POLYMORPHISMS IN THE DLL3 CODING SEQUENCE | Download Table
DLL3 positively regulated P53 signaling pathway. IHC staining of (A ...
Invitrogen DLL3 Polyclonal Antibody 100 μg; Unconjugated:Antibodies ...
Hu_DLL3 CHO-S Cell Line-Human DLL3 {Host Cells} Stable Cell Line for FC ...
DLL3 expressions in various cancer cell lines. (a) Examination of DLL3 ...
Human DLL3 Protein (DLL-HM103) | KACTUS
Biotinylated Human DLL3 Protein (Primary Amine Labeling) (DLL-HM103B)
Subcellular - DLL3 - The Human Protein Atlas
3D structure model of the DLF1 basic domain complexed to DNA. A, 3D ...
DLL3 ADC峰回路转，SCLC治疗突破有望 几乎所有靶点的成药都会走过一段漫长又波折的旅程，Delta样配体3（DLL3）靶点正在经历这样 ...
Immunohistochemistry of DLL3. The cutoff value was set at 1% for DLL3 ...
Wild type DLL3 but not DLL3-S286A,T403V affects the subcellular ...
Assessment of DLL3 and CD3 Expression in Pediatric Tumor FFPE Samples ...
Representative images of DLL3 protein in small-cell lung cancer (x400 ...
1689 Evaluation of DLL3 Expression in Small Cell Lung Cancer by ...
Human DLL3 (27-215) Protein (DLL-HM13D) – KACTUS
Biotinylated Human DLL3 Protein (Primary Amine Labeling), Accession ...
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell ...
DLL3 - A Target for Small Cell Lung Cancer Treatment - DIMA Biotechnology
DLL3: Emerging Target in Tumor Therapy Treatment Strategies | KACTUS
DLL3: A New Molecular Target in Cancer - Cusabio
熙宁生物 | 精翰生物 创新型CRO
Anti-DLL3 ADC - Creative Biolabs
DLL3靶点介绍及药物研究进展-缔码生物
Delta‐like canonical Notch ligand 3 as a potential therapeutic target ...
ASCO Recap Palak Desai, MD. - ppt download
Domain organization of mammalian Notch ligands. Five mammalian ligands ...
Biochemistry of Notch ligands and Notch receptors There are five Notch ...
Delta‐like ligand 3: A promising target against small cell lung cancer ...
Analysis of Dll1-Dll3 chimeric ligands. (A) Schematic overview of ...
DLL3：下一个ADC的明星靶点？
Targeting DLL3: Innovative Strategies for Tumor Treatment
Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and ...
Delta‐like 3 localizes to neuroendocrine cells and plays a pivotal role ...
包含δ样配体3（DLL3）抗原结合结构域的蛋白质及其用途的制作方法
靶点DLL3:从基础研究到临床转化的进展汇总|肿瘤_新浪财经_新浪网
MA17.13 DLL3-targeted CAR-T Therapy of Small Cell Lung Cancer Utilizing ...
Advances in DLL3-targeted therapies for small cell lung cancer ...
The Role of DLLs in Cancer: A Novel Therapeutic Target | OTT
DLL3：肺癌治疗新希望与肿瘤研究新热点|DLL|肿瘤|表达|Notch|治疗|-健康界
靶向DLL3，安进/百济神州递交双特异性T细胞结合器临床申请 3月15日，中国国家药监局药品审评中心（CDE）官网公示， 安进 （Amgen ...
Mechanism of Action (MOA) | IMDELLTRA® (tarlatamab-dlle) HCP
2023 WCLC | 小细胞肺癌的探索：DLL3靶向药物，B7-H3 ADC 小细胞肺癌（SCLC）约占肺癌的14%，且预后不良，广泛期患者 ...
1.7亿美元首付：第一三共从默沙东引进一款DLL3/CD3双抗_财富号_东方财富网
药物研发道阻且长：盘点ADC药物十大失败案例 丨猎药人俱乐部内容团队整理 目前，由于疾病复杂度提升、监管趋严、患者招募困难等原因，新药研发周期 ...
DLL3：多赛道进击小细胞肺癌 DLL3概述Delta样配体3 (Delta-Like Ligand 3, DLL3)是Notch配体家族的 ...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary ...
靶向DLL3的多特异性抗原结合分子及其用途的制作方法
Frontiers | Advances in DLL3-targeted therapies for small cell lung ...
Double immunofluorescence staining of delta‐like 3 (DLL3) and CHGA in ...
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
The expression levels of delta‐like 3 (DLL3) in... | Download ...
ETN029: A DLL3-targeted peptide theranostic for solid tumors | Drug ...
Delta-like Ligand 3 (DLL3) in Targeted Cancer Therapy
研究报告 | 靶向DLL3药物在研现状 DLL3靶点介绍DLL3是一种高度肿瘤选择性的细胞表面靶点，主要表达于神经或者神经内分泌肿瘤，包括小 ...
Novel mutations in DLL3, a somitogenesis gene encoding a ligand for the ...
勃林格殷格翰小细胞肺癌新药DLL3/CD3双抗II期临床试验在中国获批
The pattern of delta‐like 3 (DLL3) expression in the gastrointestinal ...
DLL3靶向三特异性蛋白及其使用方法与流程
AMG 757 activity against DLL3-expressing prostate cancer cells in ...
Notch
Frontiers | Identification of DLL3-related genes affecting the ...
研究报告 | 靶向DLL3药物在研现状|细胞|表达|临床|肿瘤|治疗|-健康界
【最强组合】肺癌治疗热门靶点——DLL3 & Notch - 知乎
记住所有FDA生物药 | DLL3×CD3双抗 | Tarlatamab 塔拉塔单抗 | 广泛期小细胞肺癌 - 知乎
【药海听涛】传奇的DLL3，还是DLL3的传奇？ 年底忙于俗务，连看点颇多的ESMO都来不及认真跟进，只看了一些摘要总结就有印象Amgen和 ...
针对小细胞肺癌靶向DLL3的新疗法-MedSci.cn
医药魔方
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small ...
| The 3D structures of Wnt proteins in different species. (A-C) 3D ...
A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces ...
Targets and biomarkers for targeted therapy. DLL3, delta-like protein ...
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary ...
恒瑞医药「DLL3-ADC」研究数据亮相_药智新闻
Frontiers | Engineered exosomes restore miR-508-5p expression in ...
ESMO 2024: DLL-3 Targeted Therapy for Neuroendocrine Prostate Cancer
Slide 9
Identification of DLL3-related genes affecting the prognosis of ...
.jpg)
